Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, Iraq | NETWORK |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The ability of spermatozoa to produce reactive oxygen species (ROS) has been respected since the 1940's. Oxidative stress limits the functional competence of mammalian spermatozoa via lipid peroxidation, the induction of oxidative DNA damage and the formation of protein adducts. Nitric oxide (NO) is a free radical generated from the oxidation of L-arginine to L-citrulline by reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent NO synthases. Several studies suggest that the overproduction of this free radical and the subsequent excessive exposure to oxidative conditions have a potential pathogenetic implication, which due to the reduction of sperm motility. The present study was conducted to study the effect of Zn supplementation on the levels of NO synthase and arginase in semen of patients with asthenozoospmia.
Previous studies suggest that high concentrations of NO play an injurious consequence on spermatozoa kinetic characteristics. These studies reported that NO may react with superoxide or hydrogen peroxide, resulting in the production of peroxinitrite, hydroxyl radical, or singlet oxygen, which cause oxidation of sperm membrane lipids and thiol proteins. NO also may inhibit cellular respiration by nitro-sylation of heme in mitochondrial enzymes, aconitase, and glyceraldehyde phosphate dehydrogenase, leading to a reduction of adenosine triphosphate and that is due to loss of motility of spermatozoa.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single group | Single group: each participant receive same intervention (zinc sulfate) throughout study (non-randomized) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| zinc sulfate | Dietary Supplement | every participant took two capsules of zinc sulfate per day for three months (each one 220mg) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Nitric oxide synthase activity | at the end of three months |
| Measure | Description | Time Frame |
|---|---|---|
| Arginase activity | at the end of three months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
this study includes 60 fertile male partners from couples who had consulted the infertility clinic of babil hospital of maternity (Hilla city/ IRAQ).
Not provided
| Name | Affiliation | Role |
|---|---|---|
| mahmoud H. hadwan, phD | babylon university / Iraq | Principal Investigator |
| Lamia A. Almashhedy, phD | Babylon university/Iraq | Study Chair |
| abdulrrazaq S. Alsalman, phD | Babylon university/Iraq | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Babylon university/ college of science | Hillah | Hilla | IQ | Iraq |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24383664 | Derived | Hadwan MH, Almashhedy LA, Alsalman AR. Study of the effects of oral zinc supplementation on peroxynitrite levels, arginase activity and NO synthase activity in seminal plasma of Iraqi asthenospermic patients. Reprod Biol Endocrinol. 2014 Jan 3;12:1. doi: 10.1186/1477-7827-12-1. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D053627 | Asthenozoospermia |
| ID | Term |
|---|---|
| D007248 | Infertility, Male |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019287 | Zinc Sulfate |
| ID | Term |
|---|---|
| D013431 | Sulfates |
| D013464 | Sulfuric Acids |
| D013456 | Sulfur Acids |
| D013457 | Sulfur Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
| D007246 |
| Infertility |
| D052801 | Male Urogenital Diseases |
| D007287 |
| Inorganic Chemicals |
| D017967 | Zinc Compounds |